Congenital disorders of glycosylation

Gene: STT3A

Green List (high evidence)

STT3A (STT3A, catalytic subunit of the oligosaccharyltransferase complex)
EnsemblGeneIds (GRCh38): ENSG00000134910
EnsemblGeneIds (GRCh37): ENSG00000134910
OMIM: 601134, Gene2Phenotype
STT3A is in 6 panels

5 reviews

Achchuthan Shanmugasundram (Genomics England Curator)

The mode of inheritance of this gene has been updated to 'BOTH monoallelic and biallelic, autosomal or pseudoautosomal' following NHS Genomic Medicine Service approval.
Created: 1 Feb 2023, 9:14 a.m. | Last Modified: 1 Feb 2023, 9:14 a.m.
Panel Version: 3.4

Arina Puzriakova (Genomics England Curator)

Comment on mode of inheritance: Should be updated from biallelic to both mono- and biallelic at the next GMS panel update as per review by Zornitza Stark. Both MOIs are also now recognised in OMIM.
Created: 18 Jul 2022, 2:44 p.m. | Last Modified: 18 Jul 2022, 2:44 p.m.
Panel Version: 2.91
Comment on list classification: There is enough evidence to support a gene-disease association, and so STT3A should be promoted from Amber to Green at the next GMS panel update (added 'for-review' tag).

At least 7 individuals from 3 unrelated families reported in literature, with 2 different homozygous variants in STT3A, as well as an additional case indicated by expert reviewer.
Created: 15 Oct 2020, 3:22 p.m. | Last Modified: 15 Oct 2020, 3:22 p.m.
Panel Version: 2.16

Zornitza Stark (Australian Genomics)

Green List (high evidence)

New MOI

PMID: 34653363 - 16 patients from 9 families with new AD mode of inheritance (both de novo and inherited). All variants were missense within/around acritical active/catalytic sites. Patients aged 3-55yo, with children noted to be "healthy" until reaching young adulthood
Clinical features include dysmorphic features, macrocephaly (6/16), mild-moderate ID/DD (10/16), short stature (8/16), skeletal abnormalities (10/16), muscle cramps (7/16).
Functional studies verifies AR disease is caused by LOF variants, whereas the AD variants cause DN proven by cotransfection in WT yeast resulting in impaired glycosylation (protein levels unchanged).
Created: 4 Dec 2021, 8:01 a.m. | Last Modified: 4 Dec 2021, 8:01 a.m.
Panel Version: 2.78
Bi-allelic variants: Three families reported to date.
Created: 22 Jul 2020, 9:55 a.m. | Last Modified: 4 Dec 2021, 8:01 a.m.
Panel Version: 2.78

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
Congenital disorder of glycosylation, type Iw; OMIM #615596

Publications

Variants in this GENE are reported as part of current diagnostic practice

Sarah Leigh (Genomics England Curator)

The rating of this gene has been updated following NHS Genomic Medicine Service approval.
Created: 3 Mar 2022, 11:11 a.m. | Last Modified: 3 Mar 2022, 11:17 a.m.
Panel Version: 2.80
Comment when marking as ready: Associated with phenotype in OMIM, not in G2P / DD. One published variant reported and expert reviewer reported an additional variant.
Created: 19 Dec 2016, 2:55 p.m.

Daniel Ungar (University of York, Department of Biology)

Green List (high evidence)

only one patient described in the literature, but I do know of a second patient being treated in the UK.
Created: 12 Dec 2016, 2:41 p.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Publications

Details

Mode of Inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Sources
  • NHS GMS
  • Expert Review Green
  • UKGTN
  • Other
Phenotypes
  • Congenital disorder of glycosylation, type Iw, autosomal dominant, OMIM:619714
  • Congenital disorder of glycosylation, type Iw, autosomal recessive, OMIM:615596
OMIM
601134
Clinvar variants
Variants in STT3A
Penetrance
Complete
Publications
Panels with this gene

History Filter Activity

1 Feb 2023, Gel status: 3

Removed Tag

Achchuthan Shanmugasundram (Genomics England Curator)

Tag Q3_22_MOI was removed from gene: STT3A.

1 Feb 2023, Gel status: 3

Added New Source, Set mode of inheritance

Achchuthan Shanmugasundram (Genomics England Curator)

Source NHS GMS was added to STT3A. Mode of inheritance for gene STT3A was changed from BIALLELIC, autosomal or pseudoautosomal to BOTH monoallelic and biallelic, autosomal or pseudoautosomal

18 Jul 2022, Gel status: 3

Set mode of inheritance

Arina Puzriakova (Genomics England Curator)

Mode of inheritance for gene: STT3A was changed from BIALLELIC, autosomal or pseudoautosomal to BIALLELIC, autosomal or pseudoautosomal

18 Jul 2022, Gel status: 3

Set Phenotypes

Arina Puzriakova (Genomics England Curator)

Phenotypes for gene: STT3A were changed from Congenital disorder of glycosylation, type Iw, 615596 to Congenital disorder of glycosylation, type Iw, autosomal dominant, OMIM:619714; Congenital disorder of glycosylation, type Iw, autosomal recessive, OMIM:615596

18 Jul 2022, Gel status: 3

Set publications

Arina Puzriakova (Genomics England Curator)

Publications for gene: STT3A were set to 23842455; 28424003; 30701557

18 Jul 2022, Gel status: 3

Added Tag

Arina Puzriakova (Genomics England Curator)

Tag Q3_22_MOI tag was added to gene: STT3A.

3 Mar 2022, Gel status: 3

Removed Tag

Sarah Leigh (Genomics England Curator)

Tag for-review was removed from gene: STT3A.

3 Mar 2022, Gel status: 3

Added New Source, Status Update

Sarah Leigh (Genomics England Curator)

Source Expert Review Green was added to STT3A. Rating Changed from Amber List (moderate evidence) to Green List (high evidence)

15 Oct 2020, Gel status: 2

Set Phenotypes

Arina Puzriakova (Genomics England Curator)

Phenotypes for gene: STT3A were changed from ?Congenital disorder of glycosylation, type Iw 615596 to Congenital disorder of glycosylation, type Iw, 615596

15 Oct 2020, Gel status: 2

Set publications

Arina Puzriakova (Genomics England Curator)

Publications for gene: STT3A were set to 23842455

15 Oct 2020, Gel status: 2

Entity classified by Genomics England curator

Arina Puzriakova (Genomics England Curator)

Gene: stt3a has been classified as Amber List (Moderate Evidence).

15 Oct 2020, Gel status: 2

Added Tag

Arina Puzriakova (Genomics England Curator)

Tag for-review tag was added to gene: STT3A.

19 Dec 2016, Gel status: 2

panel promoted to version 1

Sarah Leigh (Genomics England Curator)

Promoted to V1 19th December 2016

19 Dec 2016, Gel status: 2

Gene classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

This gene has been classified as Amber List (Moderate Evidence).

19 Dec 2016, Gel status: 2

Set publications

Sarah Leigh (Genomics England Curator)

Publications for STT3A were set to 23842455

19 Dec 2016, Gel status: 2

Gene classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

This gene has been classified as Amber List (Moderate Evidence).

1 Dec 2016, Gel status: 1

Added New Source

Sarah Leigh (Genomics England Curator)

STT3A was added to Congenital disorders of glycosylationpanel. Source: UKGTN

1 Dec 2016, Gel status: 0

Created

Sarah Leigh (Genomics England Curator)

STT3A was created by sleigh

1 Dec 2016, Gel status: 0

Added New Source

Sarah Leigh (Genomics England Curator)

STT3A was added to Congenital disorders of glycosylationpanel. Sources: Other